UNSPSC 51385101: Amixetrine
Commodity
Code facts
- Part of
-
-
51000000
-
51380000
- 51385100
-
51380000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51385101
Definition
This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7UL287YTPJ, chemically known as pyrrolidine, n-(2-phenyl-2-isoamyloxy)ethyl- but generally known as amixetrine, which bears US NIH Compound Identifier 71911. Amixetrine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amixetrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05464MIG.
Read the full definition
The term AMIXETRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). AMIXETRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amixetrine under HS 29339990 and SITC 51577. As of Q4 2014, AMIXETRINE remains the US FDA Preferred Term for this commodity. Amixetrine bears US NLM identifiers UMLS ID C0051695 and NCI Concept Code C73072. SMILES: O(C(CN1CCCC1)C1CCCCC1)CCC(C)C.
About UNSPSC 51385101
UNSPSC 51385101 Amixetrine (Commodity) does not align with recent state and local procurement activity tagged under this code. The three recent opportunities record naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic pharmaceuticals and OTC products — none of which are amixetrine or chemically related compounds. The code shows little relevant recent activity; the mismatch between the nominal commodity (amixetrine, a tricyclic antidepressant) and the actual solicitations suggests tagging inconsistency in the underlying procurement records.
Recent opportunities under this code span health and human services agencies and cooperative purchasing vehicles across Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS) due July 26, 2023 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026 exploring direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in multiple states including Oregon. The MMCAP solicitation expects awards effective July 1, 2026 through authorized wholesalers with a 3 percent administrative fee structure and price weighting at 75 percent of evaluation. Given the code-commodity mismatch, validation against the actual UNSPSC assignments in your pipeline is warranted before pursuing activity tagged to this code.
Quick answers
What is UNSPSC 51385101?
UNSPSC 51385101 is Amixetrine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51385101?
UNSPSC 51385101 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51385101
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code